Literature DB >> 22082660

Morphologic and functional correlates of synaptic pathology in the cathepsin D knockout mouse model of congenital neuronal ceroid lipofuscinosis.

Sabine Koch1, Svetlana M Molchanova, Ann K Wright, Andrew Edwards, Jonathan D Cooper, Tomi Taira, Thomas H Gillingwater, Jaana Tyynelä.   

Abstract

Mutations in the cathepsin D (CTSD) gene cause an aggressive neurodegenerative disease (congenital neuronal ceroid lipofuscinosis) that leads to early death. Recent evidence suggests that presynaptic abnormalities play a major role in the pathogenesis of CTSD deficiencies. To identify the early events that lead to synaptic alterations, we investigated synaptic ultrastructure and function in presymptomatic CTSD knockout (Ctsd) mice. Electron microscopy revealed that there were significantly greater numbers of readily releasable synaptic vesicles present in Ctsd mice than in wild-type control mice as early as postnatal day 16. The size of this synaptic vesicle pool continued to increase with disease progression in the hippocampus and thalamus of the Ctsd mice. Electrophysiology revealed a markedly decreased frequency of miniature excitatory postsynaptic currents (mEPSCs) with no effect on paired-pulse modulation of the evoked excitatory post synaptic potentials in the hippocampus of Ctsd mice. The reduced mEPSCs frequency was observed before the appearance of epilepsy or any morphologic sign of synaptic degeneration. Taken together, these data indicate that CTSD is required for normal synaptic function and that a failure in synaptic trafficking or recycling may bean early and important pathologic mechanism in Ctsd mice; these presynaptic abnormalities may initiate synaptic degeneration in advance of subsequent neuronal loss.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22082660      PMCID: PMC3242052          DOI: 10.1097/NEN.0b013e318238fc28

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  36 in total

1.  Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice.

Authors:  P F Chapman; G L White; M W Jones; D Cooper-Blacketer; V J Marshall; M Irizarry; L Younkin; M A Good; T V Bliss; B T Hyman; S G Younkin; K K Hsiao
Journal:  Nat Neurosci       Date:  1999-03       Impact factor: 24.884

2.  Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements.

Authors:  Nicholas A DiProspero; Er-Yun Chen; Vinod Charles; Markus Plomann; Jeffrey H Kordower; Danilo A Tagle
Journal:  J Neurocytol       Date:  2004-09

3.  Functional maturation of CA1 synapses involves activity-dependent loss of tonic kainate receptor-mediated inhibition of glutamate release.

Authors:  Sari E Lauri; Aino Vesikansa; Mikael Segerstråle; Graham L Collingridge; John T R Isaac; Tomi Taira
Journal:  Neuron       Date:  2006-05-04       Impact factor: 17.173

4.  Heterogeneity of release probability, facilitation, and depletion at central synapses.

Authors:  L E Dobrunz; C F Stevens
Journal:  Neuron       Date:  1997-06       Impact factor: 17.173

5.  Proteolytic degradation of glutamate decarboxylase mediates disinhibition of hippocampal CA3 pyramidal cells in cathepsin D-deficient mice.

Authors:  Tokiko Shimizu; Yoshinori Hayashi; Ryo Yamasaki; Jun Yamada; Jian Zhang; Kiyoharu Ukai; Masato Koike; Kazunori Mine; Kurt von Figura; Christoph Peters; Paul Saftig; Takaichi Fukuda; Yasuo Uchiyama; Hiroshi Nakanishi
Journal:  J Neurochem       Date:  2005-06-30       Impact factor: 5.372

6.  Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice.

Authors:  Tuhin Virmani; Praveena Gupta; Xinran Liu; Ege T Kavalali; Sandra L Hofmann
Journal:  Neurobiol Dis       Date:  2005-11       Impact factor: 5.996

7.  A mutation in the cathepsin D gene (CTSD) in American Bulldogs with neuronal ceroid lipofuscinosis.

Authors:  Tomoyuki Awano; Martin L Katz; Dennis P O'Brien; Jeremy F Taylor; Jason Evans; Shahnawaz Khan; Istvan Sohar; Peter Lobel; Gary S Johnson
Journal:  Mol Genet Metab       Date:  2006-01-04       Impact factor: 4.797

Review 8.  Neuronal ceroid lipofuscinoses.

Authors:  Anu Jalanko; Thomas Braulke
Journal:  Biochim Biophys Acta       Date:  2008-11-24

Review 9.  Towards understanding the neuronal ceroid lipofuscinoses.

Authors:  Alfried Kohlschütter; Angela Schulz
Journal:  Brain Dev       Date:  2009-02-04       Impact factor: 1.961

10.  Mice deficient for the lysosomal proteinase cathepsin D exhibit progressive atrophy of the intestinal mucosa and profound destruction of lymphoid cells.

Authors:  P Saftig; M Hetman; W Schmahl; K Weber; L Heine; H Mossmann; A Köster; B Hess; M Evers; K von Figura
Journal:  EMBO J       Date:  1995-08-01       Impact factor: 11.598

View more
  12 in total

1.  The mitochondrial protein Sideroflexin 3 (SFXN3) influences neurodegeneration pathways in vivo.

Authors:  Leire M Ledahawsky; Maria Eirini Terzenidou; Ruairidh Edwards; Rachel A Kline; Laura C Graham; Samantha L Eaton; Dinja van der Hoorn; Helena Chaytow; Yu-Ting Huang; Ewout J N Groen; Anna A L Motyl; Douglas J Lamont; Kostas Tokatlidis; Thomas M Wishart; Thomas H Gillingwater
Journal:  FEBS J       Date:  2022-02-06       Impact factor: 5.622

Review 2.  Therapeutic landscape for Batten disease: current treatments and future prospects.

Authors:  Tyler B Johnson; Jacob T Cain; Katherine A White; Denia Ramirez-Montealegre; David A Pearce; Jill M Weimer
Journal:  Nat Rev Neurol       Date:  2019-03       Impact factor: 42.937

3.  Altered Cerebellar Short-Term Plasticity but No Change in Postsynaptic AMPA-Type Glutamate Receptors in a Mouse Model of Juvenile Batten Disease.

Authors:  Dorota Studniarczyk; Elizabeth L Needham; Hannah M Mitchison; Mark Farrant; Stuart G Cull-Candy
Journal:  eNeuro       Date:  2018-05-17

4.  A tailored Cln3Q352X mouse model for testing therapeutic interventions in CLN3 Batten disease.

Authors:  Logan Langin; Tyler B Johnson; Attila D Kovács; David A Pearce; Jill M Weimer
Journal:  Sci Rep       Date:  2020-06-29       Impact factor: 4.379

5.  Cathepsin D Variants Associated With Neurodegenerative Diseases Show Dysregulated Functionality and Modified α-Synuclein Degradation Properties.

Authors:  Josina Bunk; Susy Prieto Huarcaya; Alice Drobny; Jan Philipp Dobert; Lina Walther; Stefan Rose-John; Philipp Arnold; Friederike Zunke
Journal:  Front Cell Dev Biol       Date:  2021-02-11

6.  Photoreceptor phagosome processing defects and disturbed autophagy in retinal pigment epithelium of Cln3Δex1-6 mice modelling juvenile neuronal ceroid lipofuscinosis (Batten disease).

Authors:  Silène T Wavre-Shapton; Alessandra A Calvi; Mark Turmaine; Miguel C Seabra; Daniel F Cutler; Clare E Futter; Hannah M Mitchison
Journal:  Hum Mol Genet       Date:  2015-10-08       Impact factor: 6.150

7.  Molecular neuropathology of the synapse in sheep with CLN5 Batten disease.

Authors:  Inês S Amorim; Nadia L Mitchell; David N Palmer; Stephen J Sawiak; Roger Mason; Thomas M Wishart; Thomas H Gillingwater
Journal:  Brain Behav       Date:  2015-10-09       Impact factor: 2.708

8.  Proteomic mapping of differentially vulnerable pre-synaptic populations identifies regulators of neuronal stability in vivo.

Authors:  Maica Llavero Hurtado; Heidi R Fuller; Andrew M S Wong; Samantha L Eaton; Thomas H Gillingwater; Giuseppa Pennetta; Jonathan D Cooper; Thomas M Wishart
Journal:  Sci Rep       Date:  2017-09-29       Impact factor: 4.379

9.  Cathepsins in neuronal plasticity.

Authors:  Amanda Phuong Tran; Jerry Silver
Journal:  Neural Regen Res       Date:  2021-01       Impact factor: 5.135

10.  Studying synapses in human brain with array tomography and electron microscopy.

Authors:  Kevin R Kay; Colin Smith; Ann K Wright; Alberto Serrano-Pozo; Amy M Pooler; Robert Koffie; Mark E Bastin; Thomas H Bak; Sharon Abrahams; Katherine J Kopeikina; Declan McGuone; Matthew P Frosch; Thomas H Gillingwater; Bradley T Hyman; Tara L Spires-Jones
Journal:  Nat Protoc       Date:  2013-06-20       Impact factor: 13.491

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.